More and more women with a breast cancer diagnosis are advised to have their biopsied tumor tissue analyzed through genomic tests such as Oncotype DX or Mammaprint. In contrast to genetic testing that analyzes a single gene and its role in transmitting certain traits or conditions from parent to child, …
According to what we know now, only 5 to 10% of breast cancers in the United States are linked to an inherited gene mutation. Of those, half are linked to abnormal structural changes in the BRCA1 or the BRCA2 gene, both of whose functions are to repair damaged DNA by …
National Breast Cancer Coalition 2017 Advocate Leadership Summit Washington, DC, from May 20-23, 2017 Renaissance Arlington Capital View Hotel, Arlington, VA The NBCC Advocate Leadership Summit is a premier training and networking event for serious advocates seeking to take action to end breast cancer. The 2017 Advocate Leadership Summit, …
Sunday, July 9, 2017 – Friday, July 14, 2017 La Jolla, CA at the Estancia La Jolla Hotel The Project LEAD® Institute is a five-day intensive science course for breast cancer advocates covering the basics of cancer biology, genetics, epidemiology, research design and advocacy. The course provides a foundation of …
In an exciting initiative for 2017, Breast Cancer Care and Research Fund (BCCRF) is launching a new program that will focus specifically on metastatic breast cancer. Our first upcoming action is to embed on our website a clinical trial matching tool, specifically designed for metastatic breast cancer patients. Metastatic Trial …
An Open Letter to Breast Cancer Researchers: What you do is extremely important and provides hope to those like me living with metastatic breast cancer. The projects you choose, and the collaborations and advances you make, can be vital to ending the set of diseases known as breast cancer, thereby …
